MYRNA SUTERA: Open Payments
NPI 1386146355 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,034 in 46 payments from 15 companies in 2025. Trend: 2023 $332 · 2024 $842 · 2025 $1,034
Food & beverage: $1,034
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 12 | $332 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $146 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $140 |
| PFIZER INC. | 3 | $72 |
| Novartis Pharmaceuticals Corporation | 2 | $51 |
| HEARTFLOW, INC. | 2 | $39 |
| E.R. Squibb & Sons, L.L.C. | 2 | $36 |
| Ionis Pharmaceuticals, Inc. | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 1 | $35 |
| SCPHARMACEUTICALS INC. | 2 | $34 |
Products named: LifeVest, JARDIANCE, REPATHA, VYNDAQEL, LEQVIO, FFRct, ELIQUIS, TRYNGOLZA.
Industry payments across DE — which companies pay providers there.
